On July 15, according to market data, the Hong Kong-listed company Leading Medical Biotechnology (HK0399) rose by over 10% during trading, with a current trading volume of 8 million Hong Kong dollars.
Leading Medical Biotechnology previously announced plans to acquire the full equity of blockchain project Conflux to expand its layout in the blockchain field, with two founding members of Conflux currently serving as its executive directors.






